Medical devices, healthcare technology and the business of care
510(k) clearance · K260708

Vein360 Reprocessed LithoVue Digital Flexible Ureteroscope (Standard Deflection); Vein360 Reprocessed LithoVue Digital Flexible Ureteroscope (Reverse Deflection)

Vein 360 · Decision date Oct 20, 2026

MEDTECHLEDGER EXPLANATIONK260708

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 20 October 2026 for K260708, a traditional 510(k) from Vein 360 of Cincinnati, Ohio, received 4 March 2026. The submission covers two named configurations: the Vein360 Reprocessed LithoVue Digital Flexible Ureteroscope (Standard Deflection) and the same device with Reverse Deflection. Both fall under regulation 876.1500, product code FGB, in the Gastroenterology/Urology specialty. SESE means clearance to market, not PMA approval.

The record identifies the products as reprocessed flexible ureteroscopes and does not describe the specific components, materials or changes assessed, nor any predicate comparison. The review was not handled by a third party, was not a combination product, and no predetermined change control plan was authorized. The linked summary document was not available in the public information, so performance data, indications and reprocessing validation remain unknown here.

The decision date is recorded as 2026-10-20, with the public page last updated 9 November 2026. No clinical or legal conclusions are drawn from the clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Oct 20, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260708
Regulatory pathway
510(k) premarket notification
Applicant
Vein 360
Product code
FGB
Decision code
SESE
Decision date
Oct 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ureteroscope And Accessories, Flexible/Rigid.

Applicant
Vein 360
Product code
FGB
FDA device class
2

FDA decision timeline

  1. K260708 received

    Application receipt date recorded by FDA.

  2. K260708 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FGB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Vein 360

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cincinnati, OH

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records